RCG
MRTX

Rock Creek Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Rock Creek Group’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,345
Closed -$876K – 231
2021
Q4 		$876K Buy
+7,345
New +$876K 0.13% 65